Exane Derivatives’s Cognyte Software CGNT Stock Holding History

Exane Derivatives’s Portfolio CGNT Stock Details CGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$42	Hold	10	–	–	﹤0.01%	743
2022 Q1	$113	Hold	10	–	–	﹤0.01%	982
2021 Q4	$157	Sell	10 -182	-95%	-$3.68K	﹤0.01%	852
2021 Q3	$3.94K	Hold	192	–	–	﹤0.01%	757
2021 Q2	$4.62K	Buy	192 +157	+449%	+$3.88K	﹤0.01%	778
2021 Q1	$973	Buy	+35	New	+$1.04K	﹤0.01%	740

Other funds holding CGNT

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Edenbrook Capital Mt. Kisco, New York $496M AUM 53.85% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ACM

American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Exane Derivatives's CGNT Position: Q2 2022 in Review

Exane Derivatives held its Cognyte Software (CGNT) position steady in Q2 2022 at 10 shares worth $42. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Exane Derivatives first reported a position in CGNT in Q1 2021 and has held it in 6 quarters since. The position peaked at $4.62K in Q2 2021. 143 funds tracked by Wall St. Rank hold CGNT as of Q2 2022.

Exane Derivatives held 10 shares of Cognyte Software worth $42 as of Q2 2022.
Exane Derivatives left its Cognyte Software share count unchanged in Q2 2022.
Cognyte Software made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #743 holding.
Exane Derivatives first reported a position in Cognyte Software in Q1 2021 and has held it in 6 quarters since.
Exane Derivatives's Cognyte Software position peaked at $4.62K in Q2 2021.
143 funds tracked by Wall St. Rank held Cognyte Software as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.